SCHEMBL7412866

SCHEMBL7412866

Cc1cc(C)c(S(=O)(=O)NC(CNS(=O)(=O)c2ccc(C(C)(C)C)cc2)C(=O)NO)c(C)c1

nearest known ligand 0.61

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MMP7 P09237 5/20 0.61
MMP9 P14780 2/20 0.61
MMP10 P09238 1/20 0.61
HSD17B2 P37059 1/20 0.46
HDAC3 O15379 3/20 0.46
HDAC8 Q9BY41 3/20 0.46
HDAC6 Q9UBN7 3/20 0.46
MAPT P10636 2/20 0.45
ALDH1A1 P00352 1/20 0.45
HDAC11 Q96DB2 2/20 0.43
GAA P10253 1/20 0.42
ALOX12 P18054 1/20 0.42
CA1 P00915 1/20 0.42
CA2 P00918 1/20 0.42
MMP1 P03956 1/20 0.42
MMP2 P08253 1/20 0.42
MMP8 P22894 1/20 0.42
MMP13 P45452 1/20 0.42
ITGAV P06756 3/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7416539 0.96 MMP7 (0.61) MMP7MMP9MMP10HSD17B2HDAC3
SCHEMBL7414393 0.89 MMP7 (0.70) MMP7MMP9MMP10HDAC3HDAC8
SCHEMBL7419489 0.89 MMP7 (0.77) MMP7MMP9MMP10HDAC3HDAC8
SCHEMBL7414547 0.88 MMP7 (0.54) MMP7MMP9MMP10MAPTGAA
SCHEMBL7418672 0.86 MMP9 (0.57) MMP7MMP9MMP10ALDH1A1CA1
SCHEMBL7423461 0.86 MMP7 (0.58) MMP7MMP9MMP10ALDH1A1CA1
SCHEMBL7413136 0.86 MMP9 (0.53) MMP7MMP9MMP10MAPTCA1
SCHEMBL7411120 0.83 MMP7 (0.54) MMP7MMP9MMP10
SCHEMBL7417547 0.83 MMP7 (0.69) MMP7MMP9MMP10HDAC3HDAC8
SCHEMBL7417364 0.83 MMP7 (0.69) MMP7MMP9MMP10HDAC3HDAC8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6218389-B1 FOR THERAPY AND PROPHYLAXIS OF ARTHRITIS, CANCER, CARDIOVASCULAR DISORDERS; SKIN DISORDERS; OCULAR DISORDERS; INFLAMMATION AND GUM DISEASES, MULTIPLE SCLEROSIS, CACHEXIA, PREVENTING LOOSENING OF PROSTHETIC DEVICES THE PROCTER & GAMBLE CO. 2001-04-17 US disclosed
EP-1009737-A2 SULFONYLAMINO SUBSTITUTED HYDROXAMIC ACID DERIVATIVES AS METALLOPROTEASE INHIBITORS THE PROCTER & GAMBLE COMPANY (US) 2000-06-21 EP disclosed
WO-1999006340-A2 SULFONYLAMINO SUBSTITUTED HYDROXAMIC ACID DERIVATIVES AS METALLOPROTEASE INHIBITORS THE PROCTER & GAMBLE COMPANY (US) 1999-02-11 WO disclosed